# Crossover Trial of AD109 in Obstructive Sleep Apnea

> **NCT04580394** · PHASE2 · COMPLETED · sponsor: **Apnimed** · enrollment: 60 (actual)

## Conditions studied

- Obstructive Sleep Apnea

## Interventions

- **DRUG:** AD109
- **DRUG:** Atomoxetine
- **DRUG:** R-oxybutynin
- **DRUG:** Placebo
- **DIAGNOSTIC_TEST:** Digit System Substitution Test

## Key facts

- **NCT ID:** NCT04580394
- **Lead sponsor:** Apnimed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-27
- **Primary completion:** 2021-05-28
- **Final completion:** 2021-05-28
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04580394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04580394, "Crossover Trial of AD109 in Obstructive Sleep Apnea". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04580394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*